Antiphospholipid antibodies in pediatric lupus nephritis

American Journal of Kidney Diseases

Volumn 29, Issue 3, 1997, Pages 355-361

  Massengill, Susan F ^a   Hedrick, Claire ^b   Ayoub, Elia M ^b   Sleasman, John W ^b   Kao, Kuo Jang ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

antiphospholipid antibodies; kidney; pediatrics; Systemic lupus erythematosus; thrombosis

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HEMOLYTIC ANEMIA; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; THROMBOCYTOPENIA; THROMBOSIS; VENEREAL DISEASE REACTION TEST;

EID: 0031050898     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90195-5     Document Type: Article

References (25)

1. Harris EN, Gharavi AE, Hughes GRV: Antiphospholipid antibodies. Clin Rheum Dis 11:591-609, 1985
2. Alarcón-Segovia D, Sanchez-Guerrero J: Primary anti phospholipid syndrome. J Rheumatol 16:482-488, 1989
3. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J, Outt HH, Harris EN, Phil M, Vilardell-Torres M, Hughes GRV: The "primary" anti phospholipid antibody syndrome: Major clinical and serologic features. Medicine 68:366-374, 1989
4. McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49:193-280, 1991
5. Sammaritano LR, Gharavi AE, Lockshin MD: Anti phospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum 20:81-96, 1990
6. 2 -Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120-4124, 1990
7. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179:457-462, 1994
8. 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 93:181-186, 1992
9. Conley CL, Hartmann RC: A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31:621-622, 1952
10. Green D, Hougie C, Kazmier FJ, Lechner K, Mannucci PM, Rizza CR, Sultan Y: Report of the working party on acquired inhibitors of coagulation: Studies of the "lupus" anticoagulant. Thromb Haemost 49:144-146, 1983
11. Petri M, Rheinschmidt BA, Whiting-O'Keefe Q, Hellmann D, Corash L: The frequency of lupus anticoagulant in systemic lupus erythematosus: A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med 106:524-531, 1987
12. Shergy WJ, Kredich DW, Pisetsky DS: The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 15:1389-1394, 1988
13. Seaman DE, Londino AV, Kwoh CK, Medsger TA, Manzi S: Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 96:1040-1045, 1995
14. Molta C, Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, Kaplan C, Clémenceau S, Castellano F, Levy M: Childhood-onset systemic lupus erythematosus: Antiphospholipid antibodies in 37 patients and their first-degree relatives. Pediatrics 92:849-853, 1993
15. Ravelli A, Caporali R, Fuccia GD, Zonta L, Montecucco C, Martini A: Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 148:398-402, 1994
16. Tan EM, Cohen AS, Fries JP, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
17. Pirani CL and L Salinas-Madrigal: Evaluation of percuaneous renal biopsy, in C. Sommers (ed): Kidney Pathology Decennial. New York, NY, Appleton-Century-Crofts, 1975, pp 109-163
18. Appel GB, Suva FG, Pirani CL, Meltzer JI, Estes D: Renal involvement in systemic lupus erythematosus (SLE): A study of 56 patients emphasizing histologic classification. Medicine 57:371-410, 1978
19. Frampton G, Hicks J, Cameron JS: Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int 39:1225-1231, 1991
20. Gleuck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M: Thrombosis in systemic lupus erythematosus: Relation to the presence of circulating anticoagulants. Arch Intern Med 145:1389-1395, 1985
21. Lockshin MD: Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 20:45-59, 1994
22. Harris EN, Hughes GRV, Gharavi AE. Antiphospholipid antibodies: An elderly statesman dons new garments. J Rheumatol 14:208-213, 1987 (suppl 13)
23. Alarcón-Segovia D, Pérez-Vazquez ME, Villa AR, Drenkard C, Cabiedes J: Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 21:275-286, 1992
24. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV: The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993-997, 1995
25. Rosove MH, Brewer PMC: Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117:303-308, 1992